Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors

Belén Rubio-Ruíz, Ana Conejo-García, Pablo Ríos-Marco, María Paz Carrasco-Jiménez, Josefa Segovia, Carmen Marco, Miguel A Gallo, Antonio Espinosa, Antonio Entrena

Research output: Contribution to journalArticlepeer-review

Abstract

Inhibition of Choline Kinase (ChoK) has been reported as a therapeutical target in the treatment of some kinds of tumor. In this paper, the design and synthesis of new non-symmetrical monocationic ChoK inhibitors is described, bearing a cationic head and an adenine moiety connected by linkers of different lengths. Docking studies indicate that the cationic head of these compounds could be inserted into the choline binding site of the enzyme, while the adenine moiety could be stabilized into the ATP binding site. Docking studies also support the difference of activity of the synthesized compounds, which depends on both the substituent at position 4 of the cationic head and the linker length, being dimethylamine and 1,4-diphenylbutane respectively, the most appropriate ones. Compounds 14 (IC(50) = 10.70 ± 0.40 μM) and 17 (IC(50) = 6.21 ± 0.97 μM) are the most potent ChoK inhibitors and suitable for further modification with a view to obtain more potent antitumor compounds.

Original languageEnglish
Pages (from-to)154-62
Number of pages9
JournalEuropean Journal of Medicinal Chemistry
Volume50
DOIs
Publication statusPublished - Apr 2012

Keywords

  • Adenosine Triphosphate
  • Cell Proliferation
  • Choline
  • Choline Kinase
  • Drug Design
  • Enzyme Inhibitors
  • Hep G2 Cells
  • Humans
  • Magnetic Resonance Spectroscopy
  • Models, Molecular
  • Molecular Structure
  • Quantitative Structure-Activity Relationship

Fingerprint

Dive into the research topics of 'Design, synthesis, theoretical calculations and biological evaluation of new non-symmetrical choline kinase inhibitors'. Together they form a unique fingerprint.

Cite this